Biotech Stocks At 52-Week Highs - NUTX +8%, IOVA +7%, ATRC, CNC, CON

Several biotech stocks hit 52-week highs on September 15, 2026, with moves tied to clinical or financial updates. Nutex Health (NUTX) climbed to a 52-week high of $219 after gaining more than 8% intraday, despite previously announcing a cybersecurity breach involving data storage on its network. The company runs micro-hospitals and operates a Population Health Management Division with provider networks. AtriCure (ATRC) reached $56.02 as its heart-rhythm technologies for atrial fibrillation, including the Isolator Synergy ablation system, gained renewed attention; second-quarter revenue was $153.6 million, up 12.8%. Iovance (IOVA) rose over 7% to $9.41 on a quarterly revenue gain, while Centene (CNC) moved above $69.43 after reporting $44 billion in second-quarter premium and services revenue.